← Best Covered Calls
/ GILD
Why GILD Is an Excellent Covered Call Candidate Right Now Strong · 78/100
Gilead Sciences Inc (Healthcare) · $138.99 ·
Analysis generated Apr 13, 2026 ·
Data as of market close Apr 13
Quick Take
GILD is trading at $138.99 with RSI at 51 (neutral territory). Options IV is at 30% — 37% below its 30-day average of 48%. Neither RSI nor IV strongly favor selling calls right now. Consider waiting for better conditions or using a different strategy.
Technical Signals
RSI (14)
51
IV Today
30.1%
IV vs 30d Avg
-37%
MACD
bullish
ADX
14
MFI
38
The Setup
GILD Covered Call
LONG STOCK
100 shares @ $138.99
SHORT CALL
$150 Jun '26 · $3.26/sh
Net Cost
$13,573
Max Profit
+$1,427
Break-even
$135.73
Projected P&L at Target
+$1,427
(10.5%)
P&L at Expiry
P&L Scenarios
What happens at different GILD prices by expiry:
| GILD Price | Today | May 5 | May 27 | Jun 19 (exp) |
|---|---|---|---|---|
| $111 (-20%) | -$2,461 | -$2,455 | -$2,454 | -$2,454 |
| $118 (-15%) | -$1,784 | -$1,766 | -$1,759 | -$1,759 |
| $125 (-10%) | -$1,136 | -$1,093 | -$1,067 | -$1,064 |
| $132 (-5%) | -$542 | -$460 | -$391 | -$369 |
| $136 (-2%) | -$221 | -$114 | -$8 | +$48 |
| $139 (0%) ← now | -$24 | +$98 | +$231 | +$326 |
| $142 (+2%) | +$156 | +$292 | +$450 | +$604 |
| $146 (+5%) | +$397 | +$548 | +$735 | +$1,021 |
| $150 (+8%) ← target | +$597 | +$755 | +$955 | +$1,427 |
| $153 (+10%) | +$718 | +$877 | +$1,076 | +$1,427 |
| $160 (+15%) | +$945 | +$1,093 | +$1,263 | +$1,427 |
| $167 (+20%) | +$1,095 | +$1,220 | +$1,345 | +$1,427 |
Why This Strategy, Why Now
- RSI at 51 — neutral-bullish
- IV -37% vs avg — premiums below average, less income
- MACD bullish — stock has upward momentum
- ADX at 14 — range-bound, perfect for selling calls
- No squeeze — no imminent breakout
Key Risks
GILD has bullish momentum (MACD). If a positive catalyst emerges (earnings beat, product launch), the stock could gap past your strike. Consider rolling the call up if GILD approaches the strike before expiry.